Evidence map›Paper›PMID 30310143›Full record

GuidelineNature reviews. Urology2018

The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.

Gordan M Vujanić, Manfred Gessler, Ariadne H A G Ooms, Paola Collini, Aurore Coulomb-l'Hermine, Ellen D'Hooghe, Ronald R de Krijger, Daniela Perotti, Kathy Pritchard-Jones, Christian Vokuhl and 3 more

Erratum issued Registry-linked trialAbstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in Nature reviews. Urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05735977 (An Open Label Cohort Study Assessing the Near Infrared Fluoroscopic Macro and Microscopic Appearances of Paediatric Renal Parenchyma and Tumours Following Ex-vivo Injection of Indocyanine Green), which is not on this map. Cited by 121 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05735977 nacompletednot on this mapstarted 2023, after this paper: background citation

An Open Label Cohort Study Assessing the Near Infrared Fluoroscopic Macro and Microscopic Appearances of Paediatric Renal Parenchyma and Tumours Following Ex-vivo Injection of Indocyanine Green

TypeinterventionalSponsorBirmingham Women's and Children's NHS Foundation TrustRan2023 to 2025Enrolled12ConditionsWilms Tumor, Renal CancerArmsIndocyanine Green (ICG)
3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Gordan M VujanićDepartment of Pathology, Sidra Medicine, Doha, Qatar. gvujanic@sidra.org.
Manfred GesslerTheodor-Boveri-Institute/Biocenter, Developmental Biochemistry, Wuerzburg University, Wuerzburg, Germany.ORCID http://orcid.org/0000-0002-7915-6045
Ariadne H A G OomsPrincess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands.
Paola ColliniDepartment of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Aurore Coulomb-l'HermineSorbonne Université, Department of Pathology, Hopitaux Universitaires Est Parisien, Paris, France.
Ellen D'HoogheDepartment of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Ronald R de KrijgerPrincess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands.
Daniela PerottiMolecular Bases of Genetic Risk and Genetic Testing Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Kathy Pritchard-JonesGreat Ormond Street Institute of Child Health, University College London, London, UK.ORCID http://orcid.org/0000-0002-2384-9475
Christian VokuhlKiel Paediatric Tumour Registry, Department of Paediatric Pathology, University Hospital of Kiel, Kiel, Germany.
Marry M van den Heuvel-EibrinkPrincess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands.
Norbert GrafDepartment of Paediatric Oncology & Haematology, Saarland University, Homburg, Germany.ORCID http://orcid.org/0000-0002-2248-323X
International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG)

Funding

Cancer Research UK 17297
6 · The paper itself

Abstract

On the basis of the results of previous national and international trials and studies, the Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP-RTSG) has developed a new study protocol for paediatric renal tumours: the UMBRELLA SIOP-RTSG 2016 protocol (the UMBRELLA protocol). Currently, the overall outcomes of patients with Wilms tumour are excellent, but subgroups with poor prognosis and increased relapse rates still exist. The identification of these subgroups is of utmost importance to improve treatment stratification, which might lead to reduction of the direct and late effects of chemotherapy. The UMBRELLA protocol aims to validate new prognostic factors, such as blastemal tumour volume and molecular markers, to further improve outcome. To achieve this aim, large, international, high-quality databases are needed, which dictate optimization and international harmonization of specimen handling and comprehensive sampling of biological material, refine definitions and improve logistics for expert review. To promote broad implementation of the UMBRELLA protocol, the updated SIOP-RTSG pathology and molecular biology protocol for Wilms tumours has been outlined, which is a consensus from the SIOP-RTSG pathology panel.

Indexed as

Biomarkers, TumorBiopsyChildHumansKidneyKidney NeoplasmsNeoplasm StagingPrognosisSpecimen HandlingWilms TumorBiomarkers, Tumor

Identifiers

PMID30310143
PMCPMC7136175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.